[1] Okamoto M, Ray S S. Polymer/layered silicate nanocomposites: a review from preparation to processing. Prog. Polym. Sci., 2003, 28(11): 1539-1641.[2] 杨 丹, 袁 鹏, 何宏平. 蒙脱石/醋酸氯已定抗菌化合物的制备及其表征. 矿物岩石, 2005, 25(3): 141-144.[3] Zheng J P, Luan L, Wang H Y, et al. Study on ibuprofen/ montmorillonite intercalation composites as drug release system. Appl. Clay. Sci., 2007, 36(4): 297-301.[4] Zheng J P, Wang H Y, Zhuang H, et al. Intercalation of amido cationic drug with montmorillonite. J. Wuhan Univ. Technol., 2007, 22(2): 250-252.[5] 张彩云, 鲁传华, 方前锋,等. 蒙脱石作为5-氟尿嘧啶药物缓释制剂载体的研究. 非金属矿, 2010, 33(5): 40-42.[6] 王桂芳, 吕宪俊, 邱 俊, 等(WANG Gui-Fang, et al). 氟尿嘧啶/蒙脱石化合物的制备及其释放性能. 硅酸盐学报(Journal of the Chinese Ceramic Society), 2010, 38(4): 678-683.[7] Joshi G. V, Kevadiya B D, Patel H A, et al. Montmorillonite as a drug delivery system: intercalation and in vitro release of timolol maleate. Int. J. Pharm., 2009, 374(1/2): 53-57.[8] Joshi G. V, Kevadiya B D, Bajaj H C, et al. Design and evaluation of controlled drug delivery system of buspirone using inorganic layered clay mineral. Micropor. Mesopor. Mat., 2010, 132(3): 526-530.[9] Joshi G. V, Patel H A, Kevadiya B D, et al. Montmorillonite intercalated with vitamin B1 as drug carrier. Appl. Clay. Sci., 2009, 45(4): 248-253.[10] Park J K, Choy Y B, Oh J M, et al. Controlled release of donepezil intercalated in smectite clays. Int. J. Pharm., 2008, 359(1/2): 198-204.[11] Meng N, Zhou N L, Zhang S Q, et al. Controlled release and antibacterial activity chlorhexidine acetate (CA) intercalated in montmorillonite. Int. J. Pharm., 2009, 382(1/2): 45-49.[12] 杨建华, 路新卫, 韦莉萍, 等. 甲硝唑/蒙脱土抗菌化合物的制备及体外缓释特征. 世界华人消化杂志, 2009, 17(9): 914-917.[13] 杨晋涛, 范 宏, 卜志扬, 等(YANG Jin-Tao, et al). 蒙脱石的溶胀、蒙脱石-水悬浮液及悬浮乳液的流变特性. 硅酸盐学报(Jourual of the Chinese Ceramic Society), 2005, 33(12): 1457-1463. |